ArticleFrontiers in oncology2022

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.

Sara Elena Rebuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.